OR WAIT null SECS
April 06, 2011
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
April 01, 2011
Europe's approach to pharmacovigilance has room for improvement that European agencies are working on.
March 02, 2011
Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and type of spending made in 2010 and planned for 2011.
Bristol-Myers Squibb opens a new pediatric HIV/AIDS clinic in Tanzania.
This article is Part I of a three-part series on biopharmaceutical issues in public health, government, and developing-world markets. Part 1 focuses on drug-development. Part II, which examines manufacturing, appeared in the April 2011 of Sourcing and Management. Part III, which analyzes distribution and administration,appeared in the May 2011 issue.
February 02, 2011
The Novartis Foundation for Sustainable Development held a symposium in December 2010 to continue dialogue on how the private and public sector can work together in achieving the UN Millennium Development Goals.
USP helps to improve drug quality in 32 countries.
One year following the earthquake in Haiti, the pharmaceutical industry and private sector participate in efforts for long-term relief.